Clinical Trial: Clinical Evaluation of Arthrocentesis, Combination of Platelet-Rich Plasma and Cyclooxygenase Enzyme-2 Inhibitor in Treatment of Temporo-Mandibular Joint Anterior Displacement

U.S., March 12 -- ClinicalTrials.gov registry received information related to the study (NCT07463404) titled 'Clinical Evaluation of Arthrocentesis, Combination of Platelet-Rich Plasma and Cyclooxygenase Enzyme-2 Inhibitor in Treatment of Temporo-Mandibular Joint Anterior Displacement' on March 05.

Brief Summary: Clinical Evaluation of Arthrocentesis, Combination of Platelet-Rich Plasma and Cyclooxygenase Enzyme-2 Inhibitor in Treatment of Temporo-Mandibular Joint Anterior Displacement

Study Start Date: Dec. 01, 2023

Study Type: INTERVENTIONAL

Condition: Temporomandibular Joint Internal Derangement

Intervention: COMBINATION_PRODUCT: Inject Combination of Platelet-Rich Plasma and Cyclooxygenase Enzyme-2 Inhibitor after arthrocentesis...